NYSE - Delayed Quote USD

Alexandria Real Estate Equities, Inc. (ARE)

119.65

+0.16

(+0.13%)

At close: April 24 at 4:00 PM EDT

122.00

+2.35

(+1.96%)

Pre-Market: 4:09 AM EDT

Alexandria Real Estate Equities, Inc. Reports: 1Q24 Net Income per Share - Diluted of $0.97; and 1Q24 FFO per Share - Diluted, as Adjusted, of $2.35

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the first quarter ended March 31, 2024.

PR Newswire 2 days ago
Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Second Consecutive Year

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that it has been named one of Newsweek's Most Trustworthy Companies in America for the second consecutive year. Alexandria was selected for this prestigious annual list based on the analysis of an extensive independent survey compiled in collaboration with the publica

PR Newswire 22 days ago
Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal With insitro for a 6-Year Lease Extension at the Alexandria Center for Advanced Technologies Mega Campus in South San Francisco

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that insitro, a leading machine learning-powered drug discovery and development company, has executed an early renewal for a 6-year lease extension through August 31, 2034 for 143,188 RSF at 279 East Grand Avenue on the Alexandria Center® for Advanced Technologies – S

PR Newswire 23 days ago
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 1Q24, for an Aggregate of $5.02 per Common Share for the 12 Months Ending March 31, 2024, an Increase of 24 Cents, or 5 Percent, Over the 12 Months Ended March 31, 2023

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.27 per common share for the first quarter of 2024. The dividend is payable on April 15, 2024 to shareholders of record on March 28, 2024. The common stock dividend for the 12 months ending March 31, 2024 of $5.02 per common share represents an increase of 24 cents, or 5 percent, over the 12 months ended March 31, 2023.

PR Newswire last month
Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal and 10-Year Lease Extension With Longstanding Credit Tenant Takeda at the Alexandria Center at Kendall Square Mega Campus in Cambridge

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that an affiliate of Takeda Pharmaceutical Company Limited, a top 20 global biopharmaceutical company and longstanding credit tenant, has executed a 10-year lease extension through March 31, 2040 with strong rental rate increases for 222,925 RSF at 75/125 Binney Stree

PR Newswire last month
Alexandria Real Estate Equities, Inc. to Hold Its First Quarter 2024 Operating and Financial Results Conference Call and Webcast on April 23, 2024

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, April 23, 2024, at 3:00 p.m. Eastern Time (ET), in conjunction with the release of its first quarter 2024 operating and financial results. Alexandria will release its operating and financial results after the market closes on Monday, April 22, 2024.

PR Newswire last month
Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, continues to make a distinctive, steadfast and positive impact on the widespread and complex mental health crisis through one of the company's bedrock social responsibility pillars that prioritizes this unprecedented crisis. With more than 1 in 5 American adults living with a mental

PR Newswire last month
Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Science - Shady Grove Mega Campus in Rockville, Maryland

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today announced that AstraZeneca, a top 20 global biopharmaceutical company and longstanding Alexandria tenant, is investing $300 million in a next-generation cell therapy manufacturing facility at 9950 Medical Center Drive on the Alexandria Center® fo

PR Newswire 2 months ago
Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $400,000,000 aggregate principal amount of 5.250% senior notes due 2036 and $600,000,000 aggregate principal amount of 5.625% senior notes due 2054 (collectively, the "notes"). Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, RBC Capital Markets, LLC, Barclays Capital Inc., Mizuho Securities USA LLC, Sc

PR Newswire 2 months ago
Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes

Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering, subject to market conditions, of two tranches of senior notes (the "notes"). Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and RBC Capital Markets, LLC will act as joint book-running managers in connection with the public offering. The notes will be unsecured obligations of the Company

PR Newswire 2 months ago
Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share - Diluted of $0.54; 2023 Net Income per Share - Diluted of $0.54; and 4Q23 and 2023 FFO per Share - Diluted, As Adjusted, of $2.28 and $8.97, respectively

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the fourth quarter and year ended December 31, 2023.

PR Newswire 2 months ago
Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2023 distributions as described in the chart below. Stockholders are encouraged to consult with their own tax advisors as to their specific tax treatment of Alexandria Real Estate Equities, Inc. distributions.

PR Newswire 2 months ago
Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today celebrates the 30th anniversary of its one-of-a-kind, once-in-a-generation company. Alexandria pioneered the novel Labspace® niche and created the first-ever REIT uniquely focused on the critically important life science industry with its foundin

PR Newswire 3 months ago
Alexandria Real Estate Equities, Inc. Announces Long-Term 165,940 RSF, Full-Building Lease With Novo Nordisk for R&D Center at the Alexandria Center for Life Science - Waltham Mega Campus in Greater Boston

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today announced that Novo Nordisk, a leading global healthcare company, has executed a long-term full-building lease at 60 Sylvan Road for 165,940 RSF to anchor the Alexandria Center® for Life Science – Waltham1 mega campus in Greater Boston. 60 Sylvan

PR Newswire 4 months ago
Alexandria Real Estate Equities, Inc. Announces Long-Term 99,557 RSF Lease With CARGO Therapeutics for Its New Headquarters and R&D Center at the Alexandria Center for Life Science - San Carlos Mega Campus in the San Francisco Bay Area

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today announced that it has executed a long-term lease with CARGO Therapeutics for 99,557 RSF at 835 Industrial Road on the Alexandria Center® for Life Science – San Carlos mega campus in the San Francisco Bay Area. CARGO anticipates occupying the miss

PR Newswire 4 months ago
Alexandria Real Estate Equities, Inc. Elects Sheila McGrath to Board of Directors

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today announced that the company's board of directors has elected Sheila K. McGrath as an independent director. The board of directors has also appointed Ms. McGrath to serve as a member of the Life Science, Agtech & Advanced Technologies Committee and

PR Newswire 4 months ago
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 4Q23, an Increase of 3 Cents Over 3Q23, and an Aggregate of $4.96 per Common Share for 2023, an Increase of 24 Cents, or 5 Percent, Over 2022

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.27 per common share for the fourth quarter of 2023. The dividend is payable on January 12, 2024 to shareholders of record on December 29, 2023. The common stock dividend for the year ending December 31, 2023 of $4.96 per common share represents an increase of 24 cents, or 5 percent, over the year ended December 31, 2022.

PR Newswire 4 months ago
Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2023 Operating and Financial Results Conference Call and Webcast on January 30, 2024

Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, January 30, 2024, at 3:00 p.m. Eastern Time (ET), in conjunction with the release of its fourth quarter and year end 2023 operating and financial results. Alexandria will release its operating and financial results after the market closes on Monday, January 29, 2024.

PR Newswire 4 months ago
Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today announced an exclusive partnership with longstanding tenant Eli Lilly and Company (NYSE: LLY) to expand Lilly's innovative Gateway Labs model to the San Diego life science cluster. Launched in 2019 by Lilly in the San Francisco Bay Area, Gateway

PR Newswire 4 months ago
Alexandria Real Estate Equities, Inc. Reports: 3Q23 and YTD 3Q23 Net Income per Share - Diluted of $0.13 and $1.08, respectively; and 3Q23 and YTD 3Q23 FFO per Share - Diluted, As Adjusted, of $2.26 and $6.69, respectively

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the third quarter ended September 30, 2023.

PR Newswire 5 months ago

Performance Overview

Return	ARE	S&P 500
YTD	-4.64%	+6.33%
1-Year	+0.46%	+22.70%
3-Year	-26.15%	+21.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Alexandria Real Estate Equities, Inc. (ARE)

Alexandria Real Estate Equities, Inc. Reports: 1Q24 Net Income per Share - Diluted of $0.97; and 1Q24 FFO per Share - Diluted, as Adjusted, of $2.35

Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Second Consecutive Year

Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal With insitro for a 6-Year Lease Extension at the Alexandria Center for Advanced Technologies Mega Campus in South San Francisco

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 1Q24, for an Aggregate of $5.02 per Common Share for the 12 Months Ending March 31, 2024, an Increase of 24 Cents, or 5 Percent, Over the 12 Months Ended March 31, 2023

Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal and 10-Year Lease Extension With Longstanding Credit Tenant Takeda at the Alexandria Center at Kendall Square Mega Campus in Cambridge

Alexandria Real Estate Equities, Inc. to Hold Its First Quarter 2024 Operating and Financial Results Conference Call and Webcast on April 23, 2024

Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis

Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Science - Shady Grove Mega Campus in Rockville, Maryland

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054

Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes

Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share - Diluted of $0.54; 2023 Net Income per Share - Diluted of $0.54; and 4Q23 and 2023 FFO per Share - Diluted, As Adjusted, of $2.28 and $8.97, respectively

Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions

Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry

Alexandria Real Estate Equities, Inc. Announces Long-Term 165,940 RSF, Full-Building Lease With Novo Nordisk for R&D Center at the Alexandria Center for Life Science - Waltham Mega Campus in Greater Boston

Alexandria Real Estate Equities, Inc. Announces Long-Term 99,557 RSF Lease With CARGO Therapeutics for Its New Headquarters and R&D Center at the Alexandria Center for Life Science - San Carlos Mega Campus in the San Francisco Bay Area

Alexandria Real Estate Equities, Inc. Elects Sheila McGrath to Board of Directors

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 4Q23, an Increase of 3 Cents Over 3Q23, and an Aggregate of $4.96 per Common Share for 2023, an Increase of 24 Cents, or 5 Percent, Over 2022

Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2023 Operating and Financial Results Conference Call and Webcast on January 30, 2024

Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego

Alexandria Real Estate Equities, Inc. Reports: 3Q23 and YTD 3Q23 Net Income per Share - Diluted of $0.13 and $1.08, respectively; and 3Q23 and YTD 3Q23 FFO per Share - Diluted, As Adjusted, of $2.26 and $6.69, respectively

Performance Overview